← All trials
NCT00419146
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2001
- Primary completion
- Apr 1, 2004
- Completion date
- Apr 1, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 99
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- University of AntwerpLead sponsor
- Scandinavian Society for PsychopharmacologyCollaborator
- Shipowner Emil Stray's legacyCollaborator
- Johanne and Einar Eilertsen's research fundCollaborator
- Solveig and Johan P. Sommer's foundationCollaborator
- Josef and Haldis Andresen's legacyCollaborator
- Laxdale LtdCollaborator
- University of AntwerpStudy chair
- Diakonhjemmet HospitalCollaborator
- Stanley Medical Research InstituteCollaborator
- AstraZenecaCollaborator
- University of OsloCollaborator
- Norwegian University of Science and TechnologyCollaborator
- University of OsloStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.